Acuta Capital Partners’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-34,156
| Closed | -$4.26M | – | 51 |
|
2021
Q3 | $4.26M | Hold |
34,156
| – | – | 1.5% | 18 |
|
2021
Q2 | $4.28M | Buy |
34,156
+6,723
| +25% | +$843K | 1.71% | 19 |
|
2021
Q1 | $3.72M | Buy |
+27,433
| New | +$3.72M | 1.34% | 32 |
|
2020
Q4 | – | Sell |
-78,807
| Closed | -$5.86M | – | 55 |
|
2020
Q3 | $5.86M | Hold |
78,807
| – | – | 1.59% | 22 |
|
2020
Q2 | $6.71M | Hold |
78,807
| – | – | 1.94% | 20 |
|
2020
Q1 | $5.7M | Hold |
78,807
| – | – | 2.76% | 14 |
|
2019
Q4 | $5.35M | Buy |
+78,807
| New | +$5.35M | 1.32% | 20 |
|